[1]CurrentPatentAssignee:ORGANON&CO-US4952571,1990,A
[1]CurrentPatentAssignee:MERCK&COINC-US2019/300513,2019,A1Locationinpatent:Paragraph0816;0817
[1]CurrentPatentAssignee:CHINESEACADEMYOFSCIENCES;ShanghaiInstituteofMateriaMedica(in:CAS)-CN111393404,2020,ALocationinpatent:Paragraph0280-0282
[1]CurrentPatentAssignee:CHINESEACADEMYOFSCIENCES;ShanghaiInstituteofMateriaMedica(in:CAS)-CN111393404,2020,ALocationinpatent:Paragraph0283-0285
[1]CurrentPatentAssignee:CHINESEACADEMYOFSCIENCES;ShanghaiInstituteofMateriaMedica(in:CAS)-CN111393404,2020,A
[2]CurrentPatentAssignee:CHINAPHARMACEUTICALUNIVERSITY-CN112898286,2021,A
[3]CurrentPatentAssignee:SICHUANKELUNPHARMACEUTICALCOMPANYLIMITED-EP3964504,2022,A1
[4]CurrentPatentAssignee:SICHUANKELUNPHARMACEUTICALCOMPANYLIMITED-EP3964504,2022,A1
[5]CurrentPatentAssignee:SICHUANKELUNPHARMACEUTICALCOMPANYLIMITED-CN114053431,2022,A
Title: Pan BS, et al. An orally available non-nucleotide STING agonist with antitumor activity. Science. 2020;369(6506):eaba6098.
Title: Liu J, et al. Identification of MSA-2: An oral antitumor non-nucleotide STING agonist. Signal Transduct Target Ther. 2021;6(1):18. Published 2021 Jan 12.